LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
Smoke & Vape Shops for Sale
Clothing & Shoe Stores for Sale
Convenience Stores & Lotto Businesses For Sale
Bars, Pubs & Nightclubs for Sale
Childcare & Educational Businesses for Sale
Technology Businesses for Sale
Restaurants for Sale
Coin Laundry & Dry Cleaning Businesses for Sale
Employment & Personnel Businesses for Sale
Warehouse & Storage Businesses for Sale
Construction & Landscaping Franchise Opportunities
Fitness & Wellness Franchises for Sale
Employment & Personnel Franchise Opportunities
Transport & Shipping Franchise Opportunities
Printing, Signs & Publishing Franchise Opportunities
Manufacturing Franchises for Sale
Coffee, Bakery & Dessert Franchise Opportunities
Entertainment & Recreation Franchise Opportunities
Travel Franchise Opportunities
Healthcare & Medical Franchise Opportunities
Retail Buildings for Sale or Lease
Land & Developments for Sale
Places of Worship for Sale
Houses & Condos for Sale or Lease
Mixed Use Buildings for Sale or Rent
Industrial Buildings for Sale or Lease
Retail Spaces for Lease or Sale
Office Buildings for Sale or Rent
Apartment Buildings for Sale
Plazas for Sale
An email will be sent to registered email address.
Please select if you are: